New & Noteworthy

September 2020

Reporting to Analyze COVID-19 Antibody Titers

Visiun, Inc

Visiun has developed a new reporting capability that analyzes COVID-19 antibody titers for plasma donation, enabling health systems to identify what percentage of their tested population meets donation eligibility. These new analytics provide a breakdown from positive COVID-19 patients carrying enough of the antibody to be eligible for plasma donation. This includes the number of positive and negative antibody test results derived from the number of samples tested, as well as a categorization of the amount of antibody titration levels using defined markers for donor eligibility thresholds. Hospitals can see the percentages of samples that meet each defined threshold for plasma donation eligibility criteria.

Visiun, Inc

Request More Information

Current Issue